{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:37:00Z","timestamp":1790699820836,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06120-3","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:34:20Z","timestamp":1765737260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex disparities in bladder cancer diagnosis: evidence from the UK Biobank"],"prefix":"10.1007","volume":"44","author":[{"given":"Dorit","family":"Shweiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"issue":"7","key":"6120_CR1","first-page":"e27330","volume":"14","author":"SA Halaseh","year":"2022","unstructured":"Halaseh SA et al (2022) A review of the etiology and epidemiology of bladder cancer: all you need to know. Cureus 14(7):e27330","journal-title":"Cureus"},{"key":"6120_CR2","doi-asserted-by":"publisher","first-page":"04109","DOI":"10.7189\/jogh.13.04109","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health 13:04109","journal-title":"J Glob Health"},{"issue":"714","key":"6120_CR3","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3399\/BJGP.2021.0319","volume":"72","author":"H Harrison","year":"2022","unstructured":"Harrison H et al (2022) Risk prediction models for symptomatic patients with bladder and kidney cancer: a systematic review. Br J Gen Pract 72(714):e11\u2013e18","journal-title":"Br J Gen Pract"},{"issue":"6","key":"6120_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00345-012-0979-x","volume":"30","author":"EK Cha","year":"2012","unstructured":"Cha EK et al (2012) Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World J Urol 30(6):847\u2013852","journal-title":"World J Urol"},{"key":"6120_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134259","author":"D Jakus","year":"2023","unstructured":"Jakus D et al (2023) The impact of the initial clinical presentation of bladder cancer on histopathological and morphological tumor characteristics. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12134259","journal-title":"J Clin Med"},{"key":"6120_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010866","author":"M Catalano","year":"2023","unstructured":"Catalano M et al (2023) Inflammation in urological malignancies: the silent killer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010866","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6120_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00345-018-2206-x","volume":"36","author":"S Akhtar","year":"2018","unstructured":"Akhtar S, Al-Shammari A, Al-Abkal J (2018) Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies. World J Urol 36(6):839\u2013848","journal-title":"World J Urol"},{"issue":"4","key":"6120_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/oxfordjournals.aje.a113768","volume":"119","author":"AF Kantor","year":"1984","unstructured":"Kantor AF et al (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119(4):510\u2013515","journal-title":"Am J Epidemiol"},{"issue":"3","key":"6120_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/bjc.2014.601","volume":"112","author":"SH Vermeulen","year":"2015","unstructured":"Vermeulen SH et al (2015) Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 112(3):594\u2013600","journal-title":"Br J Cancer"},{"issue":"5","key":"6120_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjc.6604889","volume":"100","author":"X Jiang","year":"2009","unstructured":"Jiang X et al (2009) Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer 100(5):834\u2013839","journal-title":"Br J Cancer"},{"issue":"8","key":"6120_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00345-018-2257-z","volume":"36","author":"CE Bayne","year":"2018","unstructured":"Bayne CE et al (2018) Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis. World J Urol 36(8):1181\u20131190","journal-title":"World J Urol"},{"issue":"4","key":"6120_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala R et al (2008) Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134(4):981\u2013987","journal-title":"Gastroenterology"},{"issue":"5","key":"6120_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/01.AOG.0000260392.70365.5e","volume":"109","author":"AB Ryerson","year":"2007","unstructured":"Ryerson AB et al (2007) Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. Women with ovarian cancer. Obstet Gynecol 109(5):1053\u20131061","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"6120_CR14","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/bjc.2015.30","volume":"112","author":"FM Walter","year":"2015","unstructured":"Walter FM et al (2015) Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer 112(Suppl 1):S6\u201313","journal-title":"Br J Cancer"},{"issue":"4","key":"6120_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cncr.28416","volume":"120","author":"JA Cohn","year":"2014","unstructured":"Cohn JA et al (2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120(4):555\u2013561","journal-title":"Cancer"},{"issue":"3","key":"6120_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41585-023-00806-2","volume":"21","author":"P Toren","year":"2024","unstructured":"Toren P et al (2024) The sex gap in bladder cancer survival - a missing link in bladder cancer care? Nat Rev Urol 21(3):181\u2013192","journal-title":"Nat Rev Urol"},{"issue":"2","key":"6120_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J et al (2016) Gender and bladder cancer: A collaborative review of Etiology, Biology, and outcomes. Eur Urol 69(2):300\u2013310","journal-title":"Eur Urol"},{"issue":"4","key":"6120_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-011-0709-9","volume":"29","author":"H Fajkovic","year":"2011","unstructured":"Fajkovic H et al (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4):457\u2013463","journal-title":"World J Urol"},{"issue":"11","key":"6120_CR19","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/sj.bjc.6601847","volume":"90","author":"A Moran","year":"2004","unstructured":"Moran A et al (2004) Bladder cancer: worse survival in women from deprived areas. Br J Cancer 90(11):2142\u20132144","journal-title":"Br J Cancer"},{"issue":"3","key":"6120_CR20","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779","journal-title":"PLoS Med"},{"issue":"1","key":"6120_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/tau.2018.09.11","volume":"8","author":"MGK Cumberbatch","year":"2019","unstructured":"Cumberbatch MGK, Noon AP (2019) Epidemiology, aetiology and screening of bladder cancer. Transl Androl Urol 8(1):5\u201311","journal-title":"Transl Androl Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06120-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06120-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06120-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:01:54Z","timestamp":1765782114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06120-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6120"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06120-3","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Human Ethics and Consent to Participate declarations are not applicable. The UK Biobank has approval from the Northwest Multi-Centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB). Thus, researchers do not require separate ethical clearance and are operating under the RTB approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent"}}],"article-number":"39"}}